Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Clinical trial NCT03487276 · COMPLETED

Trial details

NCT number: NCT03487276
Sponsor: InflaRx GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)

Start date: 2018-02-26
Primary completion: 2019-05-27
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.